HAW 513
Generic Name: hyoscyamine/methenamine/methylene blue/phenyl salicylate
Pill imprint HAW 513 has been identified as Utira-C 0.12 mg / 81.6 mg / 10.8 mg / 36.2 mg.
Utira-C is used in the treatment of urinary tract infection and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy.
Utira-C 0.12 mg / 81.6 mg / 10.8 mg / 36.2 mg is not subject to the Controlled Substances Act.
See also related documents.
Utira-C Images
- Generic Name:
- hyoscyamine/methenamine/methylene blue/phenyl salicylate
- Imprint:
-
HAW 513
- Strength:
- 0.12 mg / 81.6 mg / 10.8 mg / 36.2 mg
- Color:
- Purple
- Size:
- 435.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- calcium sulfate
carnauba wax
D&C Red No. 27
calcium phosphate dibasic anhydrous
FD&C Blue No. 1
gelatin
hypromellose
magnesium stearate
microcrystalline cellulose
mineral oil
shellac
polyethylene glycol
povidone k30
sucrose
titanium dioxide
- Drug Class:
- Urinary antispasmodics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Hawthorn Pharmaceuticals
- National Drug Code (NDC):
- 63717-0513
Advertisement
More Utira-C resources
- Utira-C (Cerner Multum)
Search Again
